|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: BIOPURE CORP, 10-Q, EX-27.1, 2000-06-13 |
Next: USTMAN TECHNOLOGIES INC, SC 13D/A, 2000-06-13 |
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1
<CURRENCY> U.S. DOLLARS
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> OCT-31-2000
<PERIOD-START> JAN-30-2000
<PERIOD-END> APR-29-2000
<EXCHANGE-RATE> 1
<CASH> 100,848
<SECURITIES> 0
<RECEIVABLES> 479
<ALLOWANCES> 40
<INVENTORY> 2,588
<CURRENT-ASSETS> 108,094
<PP&E> 44,567
<DEPRECIATION> 18,947
<TOTAL-ASSETS> 134,256
<CURRENT-LIABILITIES> 11,946
<BONDS> 0
0
0
<COMMON> 249
<OTHER-SE> 120,310
<TOTAL-LIABILITY-AND-EQUITY> 134,256
<SALES> 710
<TOTAL-REVENUES> 710
<CGS> 1,102
<TOTAL-COSTS> 1,102
<OTHER-EXPENSES> 8,143<F1>
<LOSS-PROVISION> (14)
<INTEREST-EXPENSE> 17
<INCOME-PRETAX> (9,907)
<INCOME-TAX> 0
<INCOME-CONTINUING> (9,907)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (9,907)
<EPS-BASIC> (0.42)
<EPS-DILUTED> 0
<FN>
<F1>OTHER EXPENSES are for R&D incurred in developing product for market
</FN>
</TABLE>
|
|